ALBERT LABS INTL. CORP.
Research ALBERT LABS INTL. CORP. (VB50) on Bullrun: market cap EUR 372.07K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVB50
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 372.07K
- Financial periodFY2022
- RevenueCAD 0
- Net income-CAD 7.06M
- Free cash flow-CAD 1.50M
Valuation Snapshot
latest market cap is EUR 372.07K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2022 | CAD 0 | -CAD 7.06M | -CAD 1.50M | n/a | -0.13 | CAD 79.12K | n/a | -CAD 365.32K |
| FY2021 | CAD 0 | -CAD 1.88M | -CAD 1.05M | n/a | -0.03 | CAD 76.70K | n/a | -CAD 502.53K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | EUR 372.07K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About ALBERT LABS INTL. CORP.
Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ALBERT LABS INTL. CORP.'s market cap?
ALBERT LABS INTL. CORP.'s market capitalization is EUR 372.07K.
What does ALBERT LABS INTL. CORP. do?
Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.